Key Takeaways
- • Congress is pursuing bipartisan legislative and investigative action against private equity investment in healthcare, driven by research linking PE ownership to higher costs and lower quality care outcomes across hospitals, nursing homes, and physician practices.
- • A Senate Budget Committee investigation (January 2025) examined two major PE firms: Leonard Green & Partners (majority stake in Prospect Medical Holdings, operating urban hospitals in Connecticut, Rhode Island, Pennsylvania, and California) and Apollo Global Management (majority stake in Lifepoint Health, operating rural hospitals nationwide), with Apollo identified as the largest private equity hospital operator.
- • Recent high-profile PE-backed healthcare bankruptcies, including Steward Health Care and Prospect Medical Holdings, have galvanized political attention and public awareness of sector risks, triggering formal Senate hearings and proposed legislation including the Health Over Wealth Act.
- • PE investment in healthcare has approached $1 trillion over the past decade, with private capital concentrating in nursing homes, long-term care facilities, and physician practices alongside hospital investments, creating systemic regulatory and patient care risks.
- • Bipartisan Senate Budget Committee and Department of Health and Human Services reports document documented harms to patient care quality and cost structure tied to PE's profit-driven business models, establishing legislative momentum for heightened oversight and potential structural reforms.
Summary
Congressional scrutiny of private equity's role in American healthcare has intensified significantly, driven by mounting evidence that PE ownership structures prioritize financial returns over patient outcomes and care quality. A January 2025 Senate Budget Committee investigation marked a watershed moment, examining two major private equity firms with controlling stakes in substantial healthcare operations. Leonard Green & Partners holds a majority stake in Prospect Medical Holdings, which operates urban hospitals across Connecticut, Rhode Island, Pennsylvania, and California. Apollo Global Management maintains majority control of Lifepoint Health, which operates rural hospitals nationwide, and has been identified as the largest private equity owner and operator of hospitals in the United States.
The legislative momentum reflects bipartisan concern grounded in academic research and high-profile operational failures. Recent bankruptcies involving Steward Health Care and Prospect Medical Holdings have elevated public and political awareness of PE-driven healthcare sector distress. Researchers have published findings demonstrating connections between private equity ownership and higher healthcare costs coupled with deteriorating quality metrics. Over the past decade alone, PE investment in healthcare has approached $1 trillion, with private capital targeting hospitals, nursing homes, long-term care facilities, and physician practices across multiple sectors. This capital deployment has occurred with minimal sectoral oversight relative to the scale and systemic implications.
Congress has responded with formal investigative mechanisms and legislative proposals. The Senate Budget Committee released its bipartisan report documenting harms to both cost structures and quality outcomes caused by major PE firms' healthcare investments. The Department of Health and Human Services has similarly contributed findings supporting increased oversight. Proposed legislation, including the Health Over Wealth Act introduced by Congresswoman Pramila Jayapal and Senator Ed Markey, targets structural reforms to PE involvement in healthcare. State-level action has also emerged, with Governor Shapiro proposing reforms based on documented failures at facilities like Crozer-Chester Medical Center.
The investigation and emerging regulatory framework reflect recognition that PE business models—structured around debt leverage, management fee extraction, and financial engineering—operate in structural tension with healthcare's public health mandates. Policymakers across both parties have signaled commitment to expedited action, suggesting that legislative constraints on PE healthcare investment represent an evolving policy consensus rather than partisan outlier activity. This regulatory momentum carries significant implications for PE fund managers with healthcare portfolios and for institutional investors evaluating exposure to PE-backed healthcare assets.
The legislative momentum reflects bipartisan concern grounded in academic research and high-profile operational failures. Recent bankruptcies involving Steward Health Care and Prospect Medical Holdings have elevated public and political awareness of PE-driven healthcare sector distress. Researchers have published findings demonstrating connections between private equity ownership and higher healthcare costs coupled with deteriorating quality metrics. Over the past decade alone, PE investment in healthcare has approached $1 trillion, with private capital targeting hospitals, nursing homes, long-term care facilities, and physician practices across multiple sectors. This capital deployment has occurred with minimal sectoral oversight relative to the scale and systemic implications.
Congress has responded with formal investigative mechanisms and legislative proposals. The Senate Budget Committee released its bipartisan report documenting harms to both cost structures and quality outcomes caused by major PE firms' healthcare investments. The Department of Health and Human Services has similarly contributed findings supporting increased oversight. Proposed legislation, including the Health Over Wealth Act introduced by Congresswoman Pramila Jayapal and Senator Ed Markey, targets structural reforms to PE involvement in healthcare. State-level action has also emerged, with Governor Shapiro proposing reforms based on documented failures at facilities like Crozer-Chester Medical Center.
The investigation and emerging regulatory framework reflect recognition that PE business models—structured around debt leverage, management fee extraction, and financial engineering—operate in structural tension with healthcare's public health mandates. Policymakers across both parties have signaled commitment to expedited action, suggesting that legislative constraints on PE healthcare investment represent an evolving policy consensus rather than partisan outlier activity. This regulatory momentum carries significant implications for PE fund managers with healthcare portfolios and for institutional investors evaluating exposure to PE-backed healthcare assets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.